PRospective Evaluation of interventional StudiEs on boNe meTastases

PRospective Evaluation of interventional StudiEs on boNe meTastases - PRESENT+

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53152

Enrollment

16500

Registered

2014-05-08

Start date

2015-01-07

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone metastases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Histologic proof of malignancy; Radiographic or histologic proof of metastatic bone disease; Referred to the Department of Radiotherapy or Orthopedic Surgery; 18 years and older; Informed consent - at least - for use of routinely collected clinical data.

Exclusion criteria

Exclusion criteria: Mentally incompetent patients; Life expectancy of less than a week indicated by the treating physician.

Design outcomes

Primary

Measure	Time frame
Clinical parameters (co-morbidity, oncological history, symptoms, imaging, technical and treatment data), clinical endpoints (pain response, toxicity and survival) and patient-reported outcomes (pain scores and QoL and satisfaction with care).	—

Countries

Netherlands

Contacts

Public ContactR. Gal

Universitair Medisch Centrum Utrecht

r.gal@umcutrecht.nl088-755 5555

Outcome results